Amphastar Pharmaceuticals (AMPH) Current Deferred Revenue (2013 - 2016)
Amphastar Pharmaceuticals (AMPH) posted quarterly Current Deferred Revenue of $830000.0 for Q3 2016, up 29.08% year-over-year from $643000.0 in Q4 2015, and down 51.18% quarter-over-quarter from $1.7 million in Q2 2016.
Amphastar Pharmaceuticals (AMPH) Current Deferred Revenue (2013 - 2016) Analysis & Trends
Amphastar Pharmaceuticals' Current Deferred Revenue history runs 4 years deep, the most recent figure standing at $830000.0 for Q3 2016.
- In Q3 2016, Current Deferred Revenue rose 29.08% year-over-year to $830000.0; the TTM figure through Sep 2016 stood at $830000.0 (up 29.08% YoY), while the FY2015 annual figure was $643000.0, down 95.41% from the prior year.
- Current Deferred Revenue for Q3 2016 stood at $830000.0, down from $1.7 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $14.6 million in Q3 2014, with the low at $643000.0 in Q4 2013.
- The 4-year median for Current Deferred Revenue is $830000.0 (2016), against an average of $4.1 million.
- The sharpest annual moves came in 2014 and 2015: Current Deferred Revenue jumped 2079.32% in 2014, then tumbled 95.59% in 2015.
- Amphastar Pharmaceuticals' Current Deferred Revenue stood at $643000.0 in 2013, then surged by 2079.32% to $14.0 million in 2014, then tumbled by 95.41% to $643000.0 in 2015, then grew by 29.08% to $830000.0 in 2016.
- Business Quant data shows AMPH's Current Deferred Revenue at $830000.0 in Q3 2016, $1.7 million in Q2 2016, and $643000.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Amphastar Pharmaceuticals | 943.15 Mn | 653.02 Mn | 93.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 830,000.00 |
| Jun 30, 2016 | 1.70 Mn |
| Mar 31, 2016 | 643,000.00 |
| Dec 31, 2015 | 643,000.00 |
| Sep 30, 2015 | 643,000.00 |
| Jun 30, 2015 | 4.37 Mn |
| Mar 31, 2015 | 6.89 Mn |
| Dec 31, 2014 | 14.01 Mn |
| Sep 30, 2014 | 14.60 Mn |
| Jun 30, 2014 | 643,000.00 |
| Dec 31, 2013 | 643,000.00 |